{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T02:51:28Z","timestamp":1770346288793,"version":"3.49.0"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100011300","name":"Department of Pediatrics, University of Florida","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014434","name":"Irving Medical Center, Columbia University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014434","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.coi.2023.102353","type":"journal-article","created":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T10:53:58Z","timestamp":1687690438000},"page":"102353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["ERBIN and phosphoglucomutase 3 deficiency"],"prefix":"10.1016","volume":"84","author":[{"given":"Joshua D","family":"Milner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2023.102353_bib1","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1084\/jem.20172306","article-title":"Primary atopic disorders","volume":"215","author":"Lyons","year":"2018","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2023.102353_bib2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1146\/annurev-immunol-042718-041553","article-title":"Primary atopic disorders","volume":"38","author":"Milner","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.coi.2023.102353_bib3","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaci.2016.02.028","article-title":"TGF-beta1-induced PAI-1 contributes to a profibrotic network in patients with eosinophilic esophagitis","volume":"138","author":"Rawson","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2023.102353_bib4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2004.09.034","article-title":"Increased TGF-beta2 in severe asthma with eosinophilia","volume":"115","author":"Balzar","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2023.102353_sbref5","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.immuni.2020.11.011","article-title":"Regulatory T cell-derived TGF-beta1 controls multiple checkpoints governing allergy and autoimmunity","volume":"53","author":"Turner","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2023.102353_bib6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.coi.2019.05.002","article-title":"Genetic evidence for the role of transforming growth factor-beta in atopic phenotypes","volume":"60","author":"Weissler","year":"2019","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coi.2023.102353_sbref7","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41385-019-0214-9","article-title":"TGFbeta1 single-nucleotide polymorphism C-509T alters mucosal cell function in pediatric eosinophilic esophagitis","volume":"13","author":"Duong","year":"2020","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.coi.2023.102353_bib8","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jaci.2013.02.030","article-title":"High prevalence of eosinophilic esophagitis in patients with inherited connective tissue disorders","volume":"132","author":"Abonia","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2023.102353_bib9","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1136\/ard.2006.062224","article-title":"Asthma and airways collapse in two heritable disorders of connective tissue","volume":"66","author":"Morgan","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2023.102353_bib10","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41588-018-0063-6","article-title":"Human TGF-beta1 deficiency causes severe inflammatory bowel disease and encephalopathy","volume":"50","author":"Kotlarz","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2023.102353_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/79128","article-title":"Domain-specific mutations in TGFB1 result in Camurati-Engelmann disease","volume":"26","author":"Kinoshita","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.coi.2023.102353_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006448","article-title":"TGFbeta receptor mutations impose a strong predisposition for human allergic disease","volume":"5","author":"Frischmeyer-Guerrerio","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2023.102353_bib13","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1056\/NEJMoa055695","article-title":"Aneurysm syndromes caused by mutations in the TGF-beta receptor","volume":"355","author":"Loeys","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2023.102353_bib14","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0140-6736(66)90119-X","article-title":"Job's Syndrome. Recurrent, \"cold\", staphylococcal abscesses","volume":"1","author":"Davis","year":"1966","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2023.102353_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1542\/peds.49.1.59","article-title":"Extreme hyperimmunoglobulinemia E and undue susceptibility to infection","volume":"49","author":"Buckley","year":"1972","journal-title":"Pediatrics"},{"key":"10.1016\/j.coi.2023.102353_bib16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1385\/CRIAI:20:1:139","article-title":"The hyper-IgE syndrome","volume":"20","author":"Buckley","year":"2001","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.coi.2023.102353_bib17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0022-3476(98)70243-4","article-title":"The face of Job","volume":"133","author":"Borges","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.coi.2023.102353_bib18","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJM199903043400904","article-title":"Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder","volume":"340","author":"Grimbacher","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2023.102353_bib19","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jvs.2011.08.011","article-title":"Ruptured thoracoabdominal aneurysm in a 27-year-old with hyper IgE syndrome","volume":"55","author":"Falah","year":"2012","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.coi.2023.102353_bib20","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.anai.2015.02.016","article-title":"Cerebral aneurysm in a 12-year-old boy with a STAT3 mutation (hyper-IgE syndrome)","volume":"114","author":"Kim","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.coi.2023.102353_bib21","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.clim.2006.10.005","article-title":"Coronary artery aneurysms in patients with hyper IgE recurrent infection syndrome","volume":"122","author":"Ling","year":"2007","journal-title":"Clin Immunol"},{"key":"10.1016\/j.coi.2023.102353_bib22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/1538574418762656","article-title":"Pulmonary artery pseudoaneurysm in hyper-IgE syndrome: rare complication with successful endovascular management","volume":"52","author":"Sharma","year":"2018","journal-title":"Vasc Endovasc Surg"},{"key":"10.1016\/j.coi.2023.102353_bib23","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2169\/internalmedicine.51.6939","article-title":"Multiple intracranial aneurysms associated with hyper-IgE syndrome","volume":"51","author":"Takeuchi","year":"2012","journal-title":"Intern Med"},{"key":"10.1016\/j.coi.2023.102353_bib24","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s10875-011-9515-9","article-title":"Coronary artery abnormalities in Hyper-IgE syndrome","volume":"31","author":"Freeman","year":"2011","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coi.2023.102353_bib25","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/jor.22920","article-title":"Dysregulated TGF-beta signaling alters bone microstructure in a mouse model of Loeys-Dietz syndrome","volume":"33","author":"Dewan","year":"2015","journal-title":"J Orthop Res"},{"key":"10.1016\/j.coi.2023.102353_sbref26","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abp9940","article-title":"Epithelial-intrinsic defects in TGFbetaR signaling drive local allergic inflammation manifesting as eosinophilic esophagitis","volume":"8","author":"Laky","year":"2023","journal-title":"Sci Immunol"},{"key":"10.1016\/j.coi.2023.102353_sbref27","article-title":"Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome","volume":"217","author":"Beziat","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2023.102353_bib28","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1084\/jem.20161810","article-title":"A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis","volume":"214","author":"Schwerd","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2023.102353_bib29","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jaci.2021.02.044","article-title":"Functional and structural analysis of cytokine-selective IL6ST defects that cause recessive hyper-IgE syndrome","volume":"148","author":"Chen","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2023.102353_bib30","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3324\/haematol.2018.194233","article-title":"Selective loss of function variants in IL6ST cause Hyper-IgE syndrome with distinct impairments of T-cell phenotype and function","volume":"104","author":"Shahin","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.coi.2023.102353_bib31","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1084\/jem.20161435","article-title":"ERBIN deficiency links STAT3 and TGF-beta pathway defects with atopy in humans","volume":"214","author":"Lyons","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2023.102353_bib32","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00439-018-1910-3","article-title":"The coexistence of copy number variations (CNVs) and single nucleotide polymorphisms (SNPs) at a locus can result in distorted calculations of the significance in associating SNPs to disease","volume":"137","author":"Liu","year":"2018","journal-title":"Hum Genet"},{"key":"10.1016\/j.coi.2023.102353_bib33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1084\/jem.20140643","article-title":"mTOR inhibition rescues osteopenia in mice with systemic sclerosis","volume":"212","author":"Chen","year":"2015","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2023.102353_bib34","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1056\/NEJM199712113372403","article-title":"The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor","volume":"337","author":"Hershey","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2023.102353_bib35","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cell.2017.08.006","article-title":"Sensory neurons co-opt classical immune signaling pathways to mediate chronic itch","volume":"171","author":"Oetjen","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.coi.2023.102353_bib36","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa073687","article-title":"STAT3 mutations in the hyper-IgE syndrome","volume":"357","author":"Holland","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2023.102353_bib37","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/nature06096","article-title":"Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome","volume":"448","author":"Minegishi","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.coi.2023.102353_bib38","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10875-017-0429-z","article-title":"Gastrointestinal manifestations of STAT3-deficient hyper-IgE syndrome","volume":"37","author":"Arora","year":"2017","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coi.2023.102353_sbref39","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.jaip.2022.01.012","article-title":"Targeted IL-4Ralpha blockade ameliorates refractory allergic eosinophilic inflammation in a patient with dysregulated TGF-beta signaling due to ERBIN deficiency","volume":"10","author":"Droghini","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.coi.2023.102353_sbref40","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.jaip.2022.01.011","article-title":"Treatment of STAT3-deficient hyper-immunoglobulin E syndrome with monoclonal antibodies targeting allergic inflammation","volume":"10","author":"James","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.coi.2023.102353_bib41","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-050351","article-title":"Dupilumab for STAT3-hyper-IgE syndrome with refractory intestinal complication","volume":"148","author":"Lu","year":"2021","journal-title":"Pediatrics"},{"key":"10.1016\/j.coi.2023.102353_bib42","doi-asserted-by":"crossref","DOI":"10.1111\/pai.13770","article-title":"Remission of eczema and recovery of Th1 polarization following treatment with Dupilumab in STAT3 hyper IgE syndrome","volume":"33","author":"Matucci-Cerinic","year":"2022","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.coi.2023.102353_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108452","article-title":"Dupilumab to treat severe atopic dermatitis in autosomal dominant hyper-IgE syndrome","volume":"215","author":"Sogkas","year":"2020","journal-title":"Clin Immunol"},{"key":"10.1016\/j.coi.2023.102353_bib44","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jaip.2021.08.042","article-title":"Relieving job: dupilumab in autosomal dominant STAT3 hyper-IgE syndrome","volume":"10","author":"Staudacher","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.coi.2023.102353_bib45","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.17889","article-title":"Dupilumab treatment of eczema in a child with STAT3 hyper-immunoglobulin E syndrome","volume":"36","author":"Wang","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.coi.2023.102353_bib46","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jaci.2018.04.007","article-title":"Epithelial barrier dysfunction in desmoglein-1 deficiency","volume":"142","author":"Polivka","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2023.102353_bib47","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jaci.2015.07.047","article-title":"Neonatal-onset T(-)B(-)NK(+) severe combined immunodeficiency and neutropenia caused by mutated phosphoglucomutase 3","volume":"137","author":"Bernth-Jensen","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2023.102353_bib48","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.jaci.2014.02.025","article-title":"Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels","volume":"133","author":"Sassi","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2023.102353_bib49","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ajhg.2014.05.007","article-title":"PGM3 mutations cause a congenital disorder of glycosylation with severe immunodeficiency and skeletal dysplasia","volume":"95","author":"Stray-Pedersen","year":"2014","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.coi.2023.102353_bib50","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.jaci.2014.02.013","article-title":"Autosomal recessive phosphoglucomutase 3 (PGM3) mutations link glycosylation defects to atopy, immune deficiency, autoimmunity, and neurocognitive impairment","volume":"133","author":"Zhang","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2023.102353_bib51","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molimm.2017.06.248","article-title":"A founder mutation underlies a severe form of phosphoglutamase 3 (PGM3) deficiency in Tunisian patients","volume":"90","author":"Ben-Khemis","year":"2017","journal-title":"Mol Immunol"},{"key":"10.1016\/j.coi.2023.102353_bib52","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jaci.2016.12.951","article-title":"Detection of phosphoglucomutase-3 deficiency by lectin-based flow cytometry","volume":"140","author":"Carlson","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coi.2023.102353_sbref53","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/pai.13398","article-title":"Novel PGM3 compound heterozygous variants with IgE-related dermatitis, lymphopenia, without syndromic features","volume":"32","author":"Garcia-Garcia","year":"2021","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.coi.2023.102353_bib54","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s10875-021-01196-z","article-title":"A De Novo cause of PGM3 deficiency treated with hematopoietic stem cell transplantation","volume":"42","author":"Winslow","year":"2022","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coi.2023.102353_bib55","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10719-015-9638-y","article-title":"Glycoproteomic studies of IgE from a novel hyper IgE syndrome linked to PGM3 mutation","volume":"33","author":"Wu","year":"2016","journal-title":"Glycoconj J"},{"key":"10.1016\/j.coi.2023.102353_bib56","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.jaci.2018.12.987","article-title":"Defective glycosylation leads to defective gp130-dependent STAT3 signaling in PGM3-deficient patients","volume":"143","author":"Ben-Ali","year":"2019","journal-title":"J Allergy Clin Immunol"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791523000729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791523000729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:47:47Z","timestamp":1760604467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791523000729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":56,"alternative-id":["S0952791523000729"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2023.102353","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ERBIN and phosphoglucomutase 3 deficiency","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2023.102353","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102353"}}